Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 3,336 | 2,658 | 1,717 | 1,821 | 2,100 |
| Gross Profit | 3,336 | 2,658 | 1,717 | 1,821 | 2,100 |
| Operating Expenses | 12,151 | 13,041 | 14,385 | 15,654 | 13,519 |
| Operating Income | -8,815 | -10,383 | -12,668 | -13,833 | -11,419 |
| Interest Expense | 188 | 215 | 241 | 357 | 286 |
| Other Income | 343 | 427 | 562 | 756 | 700 |
| Pre-tax Income | -8,660 | -10,171 | -12,347 | -13,434 | -11,005 |
| Net Income Continuous | -8,660 | -10,171 | -12,347 | -13,434 | -11,005 |
| Net Income | $-8,660 | $-10,171 | $-12,347 | $-13,434 | $-11,005 |
| EPS Basic Total Ops | -0.17 | -0.20 | -0.25 | -0.29 | -0.24 |
| EPS Basic Continuous Ops | -0.17 | -0.20 | -0.25 | -0.28 | -0.24 |
| EPS Diluted Total Ops | -0.17 | -0.20 | -0.25 | -0.29 | -0.24 |
| EPS Diluted Continuous Ops | -0.17 | -0.20 | -0.25 | -0.28 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.20 | -0.25 | N/A | N/A |
| EBITDA(a) | $-8,704 | $-10,275 | $-12,560 | $-13,711 | $-11,291 |